e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Chronic cough, a1-antitrypsin deficiency and other conditions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchiectasis in alpha1-antitrypsin deficiency
A. Cruz e Costa (Coimbra, Portugal), I. Farinha (Coimbra, Portugal)
Source:
International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Session:
Chronic cough, a1-antitrypsin deficiency and other conditions
Session type:
Thematic Poster
Number:
4359
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Cruz e Costa (Coimbra, Portugal), I. Farinha (Coimbra, Portugal). Bronchiectasis in alpha1-antitrypsin deficiency. 4359
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Pulmonary administration of alpha
1
-antitrypsin for the treatment of Alpha
1
-antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 385s
Year: 2003
Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Diagnosis and management of alpha1-antitrypsin deficiency
Source: Breathe 2007; 4: 38-46
Year: 2007
Alpha-1-antitrypsin deficiency
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139
Year: 2005
a
1
-antitrypsin deficiency
Source: Eur Respir Monogr 2015; 69: 47-84
Year: 2015
Rare SERPINA1 allele Mwhitstable in patients with Alpha1-antitrypsin deficiency
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
What we have learned about alpha-1-antitrypsin deficiency
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021
Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Exacerbations of symptoms in alpha-1-antitrypsin deficiency in the UK
Source: Eur Respir J 2002; 20: Suppl. 38, 203s
Year: 2002
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ)
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Reversible dyspnoea in alpha1-antitrypsin deficiency
Source: Annual Congress 2011 - ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by Clinical Grand Round - an interactive session
Year: 2011
Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency
Source: Eur Respir J 2009; 33: 354-360
Year: 2009
Alpha-1 antitrypsin deficiency – a potentially fatal disease
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Pulmonary disease in intermediate alpha1-antitrypsin deficient patients
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept